Navigation Links
Prescription Sleeping Pill Use Tied to Cancer
Date:8/18/2008

SAN DIEGO, Aug. 18 /PRNewswire/ -- The next time you consider popping a pill when you have trouble nodding off, it might be worth counting sheep instead. A senior psychiatrist at the Scripps Clinic Sleep Center in San Diego, Calif. has found evidence that taking sleeping pills regularly can increase the risk of skin cancer.

Daniel F. Kripke, M.D.'s article, based on a compilation of studies involving sleeping pills and cancer, has just been published in the Journal of Sleep Research. It appears with an editorial authored by Dr. Gary D. Friedman, an epidemiologist at Stanford University's School of Medicine and adjunct investigator at the Kaiser Permanente Medical Care Program who has vast experience in investigating the carcinogenic effects of drugs.

The effects of 556 person-years of taking either zaleplon (Sonata), Eszopiclone (Lunesta), ramelteon (Rozerem) and zolpidem (Ambien) were assessed, compared to a control group who took a placebo over 230 person-years. Kripke found eight non-melanoma skin cancers and four tumors of uncertain malignancy in the groups that took sleeping pills compared to none in the placebo groups.

Lab animals given high doses of hypnotic drugs are known to have developed kidney, thyroid and testicular cancers and suffer chromosome damage, which is a sign of carcinogenicity. Although a direct causal link between cancer and sleeping pills has still not been proven, Kripke urges additional studies as well as serious epidemiological investigations, given the fact that sleeping pill use is constantly rising and three new types have been put on the market in addition to Ambien (zolpidem), the most popular brand used in the United States.

"Because the compilation mixes diverse studies of several drugs and the number of cancers observed during controlled hypnotics trials remains small," Kripke writes, "this preliminary analysis should be viewed as an investigative step, rather than sufficient proof that modern h
'/>"/>

SOURCE Scripps Clinic
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Novel Technology Breaks Through Cancer Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...utomation and intelligent clinical applications ta... level , , CHICAGO, Ill., Nov. 26 /PRNewswi...ens.com/healthcare ) highlights the ACUSON S2000(...e world,s first multi-use, automated volume breast...y and Annual Meeting of the Radiological Society o...
(Date:11/25/2008)...against expanding statin use broadly in wake of AH...ov. 25 JUPITER, a clinical trial s...r risk of healthy patients with elevated CRP, shou..., according to a national poll directed at health ...n the online poll conducted by medical news site M...
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...swire-FirstCall/ -- Leaders of Schering-Plough Cor...or investors on the company,s research pipeline, h...ncludes 46 new entities in clinical trials or unde... , , "Research and development is adding st...ue our transformation," said Fred Hassan, chairman...
Breaking Medicine Technology:Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5ViroPharma Receives European Orphan Drug Designation for CAMVIA 28TM 29 6092 1ViroPharma Receives European Orphan Drug Designation for CAMVIA 28TM 29 6092 2ViroPharma Receives European Orphan Drug Designation for CAMVIA 28TM 29 6092 3ViroPharma Receives European Orphan Drug Designation for CAMVIA 28TM 29 6092 4American Cancer Society Seeks Volunteers to Help Decide Who Gets Research Grants 6090 1American Cancer Society Seeks Volunteers to Help Decide Who Gets Research Grants 6090 2Researchers identify how to switch off cancer cell genes 1186 1Earth Observation essential for geohazard mitigation 1184 1Earth Observation essential for geohazard mitigation 1184 2Earth Observation essential for geohazard mitigation 1184 3
...n,s pipeline provide support for,epigenetic and co...,data on use of Thalidomide to treat multiple myel...tCall/ -- Pharmion,Corporation reported today that...he company,s marketed and pipeline products will b...f Clinical,Oncology,s (ASCO) 43rd Annual Meeting i...
...2007 - Introgen Therapeutics, Inc.,(NASDAQ:INGN) r...N,241, the Company,s novel investigational mda-7/I...nced solid tumors., The data (Abstract #380), whic...e American Society of Gene Therapy, showed that,in...n all treated,tumors, including in those patients ...
Other Medicine Technology:Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 2Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 4Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 5Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 6Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 7Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 2Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 3
(Date:12/1/2008)...news event -- Hall of States, Room 333 -- 444 Nort..., WASHINGTON, Dec. 1 ...oming together to outline the current fiscal situa...ext Administration to provide a recovery package t...rojects and ease the burden of Medicaid costs. As ...
(Date:12/1/2008)...wire/ -- An independent study at the,University o...want to play,video games at the same time as exer... , Fifty children aged 11 and 12 were asked...mes provided by a company called Gamercize. , ...they maintained movement on,the fitness machines....
(Date:12/1/2008)...Newswire/ -- Transcept Pharmaceuticals,Inc., a p...nounced today that,Glenn A. Oclassen, President &...ticipate at the RBC Capital Markets 2008 Healthcar... "Delivering Novel Drug Solutions: The Future of D... take place on Thursday, December,11, 2008 at 1:3...
(Date:12/1/2008)... Cardinal,Health and SR...ar supply and,co-marketing agreement to offer sur...oducts from Cardinal Health and reusable health ca...ment makes Cardinal Health the exclusive manufactu...400 disposable surgical kits. In,addition, the ag...
Breaking Medicine News(10 mins):Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 3
...hKline (GSK) has reached an agreement with Eliot S... that it deceptively tried to delay competitors fr...-depressant drug Paxil.// GSK was allegedly inv... generic producers of Paxil in a bind of using fri...
...abani and his assistant Kartar Singh have been sen...of a fetus and then agreeing to abort it if it was... practitioner has been jailed for carrying out ill...ions. The perpetrators were found out when govern...
...onfections, Inc. of Dallas, Texas are tough nuts t...batch of production of Sam's Choice Belgian Milk C... almonds. This is a precautionary measure to ensur...ic to almonds that may cause a life threatening re...
... testing for HIV/AIDS in countries with high infec...er US president. // There was a stigma attached ...r those infected few decades ago and so AIDS testi... to Clinton, countries where there was no discrimi...
Other Medicine News:
The challenge for Carl Zeiss was to find innovative solutions for measurements on the eye and for preoperative computation of intraocular lenses (IOL). The result of this development work is the IOLM
Ahmed Glaucoma Valve (small size) with Pars Plana Clip .
Ahmed Glaucoma Valve.
...ompatibility is established. Provides a robust and...nsure correct positioning on the globe. Pressure R...h, when covered by Tenons tissue, acts as a Pressu...ive hypotony. The range of implants allows the sur...
Medicine Products: